Bulletin
Investor Alert

Epizyme Inc.

NAS: EPZM

GO
/marketstate/country/us

After Hours

/zigman2/quotes/200475462/composite

$

25.39

Change

+0.51 +2.05%

Volume

Volume 9,062

Feb 21, 2020, 7:08 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200475462/composite

Today's close

$ 25.48

$ 24.88

Change

-0.60 -2.35%

Day low

Day high

$24.67

$25.49

Open
Open: 25.49

52 week low

52 week high

$9.74

$27.82

Open

Market cap

$2.32B

Average volume

1.15M

P/E ratio

N/A

Rev. per Employee

$175,000

EPS

-1.61

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/epzm

MarketWatch News on EPZM

  1. Epizyme stock price target raised to $24 from $21 at Wedbush

    8:48 a.m. Dec. 19, 2019

    - Tomi Kilgore

  2. Epizyme's stock jumps on 11-0 vote from FDA adcomm

    2:54 p.m. Dec. 18, 2019

    - Jaimy Lee

  3. Epizyme's stock trades at highest intraday level seen since July 2015

    2:33 p.m. Dec. 18, 2019

    - Tomi Kilgore

  4. Epizyme's stock rockets 24% after resuming trading, after FDA committee votes in favor of Sarcoma treatment

    2:32 p.m. Dec. 18, 2019

    - Tomi Kilgore

  5. Epizyme stock price target raised to $22 from $12 at Morgan Stanley

    10:23 a.m. Dec. 6, 2019

    - Tomi Kilgore

  6. Epizyme upgraded to overweight from equal weight at Morgan Stanley

    10:23 a.m. Dec. 6, 2019

    - Tomi Kilgore

  7. Big Biotech Investors Poured $29 Million Into 2 Battered Companies

    4:00 a.m. Oct. 12, 2018

    - Barron's Online

  8. Epizyme's stock soars after FDA lifts hold on trial enrollments

    6:45 a.m. Sept. 24, 2018

    - Tomi Kilgore

  9. Epizyme downgraded to market perform from outperform at Leerink

    6:02 a.m. July 3, 2018

    - Tomi Kilgore

  10. Epizyme stock price target cut to $16 from $24 at Leerink

    6:02 a.m. July 3, 2018

    - Tomi Kilgore

  11. Epizyme stock price target raised to $25 vs. $20 at Wedbush

    6:59 a.m. May 18, 2018

    - Ciara Linnane

  12. Epizyme started at overweight with $20 stock price target at Morgan Stanley

    9:45 a.m. Jan. 10, 2018

    - Tomi Kilgore

  13. Epizyme downgraded to sector perform from outperform at RBC Capital

    6:57 a.m. Nov. 2, 2017

    - Tomi Kilgore

  14. U.S. Cheese Prices Fall

    12:32 a.m. June 25, 2016

    - Barron's Online

  15. Charting the Market

    1:08 a.m. Jan. 9, 2016

    - Barron's Online

  16. Why is Celgene So Darn Expensive?

    1:44 p.m. June 30, 2015

    - Barrons Blogs

  17. Gilead: No Big Deals

    1:40 p.m. May 13, 2015

    - Barrons Blogs

  18. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/epzm

Other News on EPZM

  1. MLCO, LVS among premarket losers

    9:15 a.m. Jan. 27, 2020

    - Seeking Alpha

  2. BLCM, NNVC, EPZM and EHTH among midday movers

    12:42 p.m. Jan. 24, 2020

    - Seeking Alpha

  3. Epizyme Gets FDA Nod for Lead Drug in Epithelioid Sarcoma

    9:57 a.m. Jan. 24, 2020

    - Zacks.com

  4. RBC likes BioMarin in premarket analyst action

    7:31 a.m. Jan. 24, 2020

    - Seeking Alpha

  5. FDA approves Epizyme's treatment for epithelioid sarcoma

    6:38 p.m. Jan. 23, 2020

    - Seeking Alpha

  6. Loading more headlines...
/news/pressrelease/company/us/epzm

Press Releases on EPZM

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.